Literature DB >> 11179305

Salivary histatin 5 is an inhibitor of both host and bacterial enzymes implicated in periodontal disease.

H Gusman1, J Travis, E J Helmerhorst, J Potempa, R F Troxler, F G Oppenheim.   

Abstract

One of the salient features of periodontitis and gingivitis is the increase in the levels of bacterial and host-derived proteolytic enzymes in oral inflammatory exudates. This study evaluated the potential of histatin 5, a 24-residue histidine-rich salivary antimicrobial protein, to inhibit these enzymes. Using biotinylated gelatin as a substrate, histatin 5 was found to inhibit the activity of the host matrix metalloproteinases MMP-2 and MMP-9 with 50% inhibitory concentrations (IC50s) of 0.57 and 0.25 microM, respectively. To localize the domain responsible for this inhibition, three peptides containing different regions of histatin 5 were synthesized and tested as inhibitors of MMP-9. Peptides comprising residues 1 to 14 and residues 4 to 15 of histatin 5 showed much lower inhibitory activities (IC50, 21.4 and 20.5 microM, respectively), while a peptide comprising residues 9 to 22 showed identical activity to histatin 5 against MMP-9. These results point to a functional domain localized in the C-terminal part of histatin 5. To evaluate the effect of histatin 5 on bacterial proteases, a detailed characterization of histatin 5 inhibition of gingipains from Porphyromonas gingivalis was carried out using purified Arg- and Lys-specific enzymes. Kinetic analysis of the inhibition of the Arg-gingipain revealed that histatin 5 is a competitive inhibitor, affecting only the Km with a K(i) of 15 microM. In contrast, inhibition of Lys-gingipain affected both the Km and Vmax, suggesting that both competitive and noncompetitive competitive processes underlie this inhibition. The inhibitory activity of histatin 5 against host and bacterial proteases at physiological concentrations points to a new potential biological function of histatin in the oral cavity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179305      PMCID: PMC98034          DOI: 10.1128/IAI.69.3.1402-1408.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

Review 1.  Bacterial proteinases as targets for the development of second-generation antibiotics.

Authors:  J Travis; J Potempa
Journal:  Biochim Biophys Acta       Date:  2000-03-07

2.  Is salivary histatin 5 a metallopeptide?

Authors:  H Gusman; U Lendenmann; J Grogan; R F Troxler; F G Oppenheim
Journal:  Biochim Biophys Acta       Date:  2001-02-09

3.  Degradation of human immunoglobulins G and M and complement factors C3 and C5 by black-pigmented Bacteroides.

Authors:  G Sundqvist; J Carlsson; B Herrmann; A Tärnvik
Journal:  J Med Microbiol       Date:  1985-02       Impact factor: 2.472

4.  An assay for detecting nanogram levels of proteolytic enzymes.

Authors:  V M Koritsas; H J Atkinson
Journal:  Anal Biochem       Date:  1995-05-01       Impact factor: 3.365

5.  Salivary enzymes. Origin and relationship to periodontal disease.

Authors:  M Nakamura; J Slots
Journal:  J Periodontal Res       Date:  1983-11       Impact factor: 4.419

6.  Fungistatic and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans.

Authors:  J J Pollock; L Denepitiya; B J MacKay; V J Iacono
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

7.  Growth-inhibitory and bactericidal effects of human parotid salivary histidine-rich polypeptides on Streptococcus mutans.

Authors:  B J MacKay; L Denepitiya; V J Iacono; S B Krost; J J Pollock
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

8.  Degradation of the human proteinase inhibitors alpha-1-antitrypsin and alpha-2-macroglobulin by Bacteroides gingivalis.

Authors:  J Carlsson; B F Herrmann; J F Höfling; G K Sundqvist
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

9.  Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans.

Authors:  F G Oppenheim; T Xu; F M McMillian; S M Levitz; R D Diamond; G D Offner; R F Troxler
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

10.  Characterization and amino acid sequence of a new acidic cysteine proteinase inhibitor (cystatin SA) structurally closely related to cystatin S, from human whole saliva.

Authors:  S Isemura; E Saitoh; K Sanada
Journal:  J Biochem       Date:  1987-10       Impact factor: 3.387

View more
  28 in total

1.  Evidence of intact histatins in the in vivo acquired enamel pellicle.

Authors:  W L Siqueira; H C Margolis; E J Helmerhorst; F M Mendes; F G Oppenheim
Journal:  J Dent Res       Date:  2010-03-29       Impact factor: 6.116

Review 2.  Intracellular Targeting Mechanisms by Antimicrobial Peptides.

Authors:  Cheng-Foh Le; Chee-Mun Fang; Shamala Devi Sekaran
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 3.  Multifunctional antimicrobial peptides: therapeutic targets in several human diseases.

Authors:  Mohamed Zaiou
Journal:  J Mol Med (Berl)       Date:  2007-01-10       Impact factor: 4.599

4.  Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.

Authors:  Deepesh Nagarajan; Tushar Nagarajan; Natasha Roy; Omkar Kulkarni; Sathyabaarathi Ravichandran; Madhulika Mishra; Dipshikha Chakravortty; Nagasuma Chandra
Journal:  J Biol Chem       Date:  2017-12-19       Impact factor: 5.157

5.  Antibacterial Peptides: Opportunities for the Prevention and Treatment of Dental Caries.

Authors:  Adam Pepperney; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2011-06       Impact factor: 4.609

6.  Alterations of the salivary secretory peptidome profile in children affected by type 1 diabetes.

Authors:  Tiziana Cabras; Elisabetta Pisano; Andrea Mastinu; Gloria Denotti; Pietro Paolo Pusceddu; Rosanna Inzitari; Chiara Fanali; Sonia Nemolato; Massimo Castagnola; Irene Messana
Journal:  Mol Cell Proteomics       Date:  2010-06-28       Impact factor: 5.911

7.  Salivary protein changes in response to acute stress in medical residents performing advanced clinical simulations: a pilot proteomics study.

Authors:  Rachel K Marvin; Muncharie B Saepoo; Simiao Ye; Donald B White; Rong Liu; Kenneth Hensley; Paul Rega; Viviane Kazan; David R Giovannucci; Dragan Isailovic
Journal:  Biomarkers       Date:  2017-01-25       Impact factor: 2.658

Review 8.  Conventional and unconventional antimicrobials from fish, marine invertebrates and micro-algae.

Authors:  Valerie J Smith; Andrew P Desbois; Elisabeth A Dyrynda
Journal:  Mar Drugs       Date:  2010-04-14       Impact factor: 5.118

9.  Saliva as a diagnostic tool for periodontal disease: current state and future directions.

Authors:  William V Giannobile; Thomas Beikler; Janet S Kinney; Christoph A Ramseier; Thiago Morelli; David T Wong
Journal:  Periodontol 2000       Date:  2009       Impact factor: 7.589

10.  Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes.

Authors:  Kazushige Midorikawa; Kazuhisa Ouhara; Hitoshi Komatsuzawa; Toshihisa Kawai; Sakuo Yamada; Tamaki Fujiwara; Kenshi Yamazaki; Koji Sayama; Martin A Taubman; Hidemi Kurihara; Koji Hashimoto; Motoyuki Sugai
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.